Volume 142, Issue 7, Pages e6 (June 2012)

Slides:



Advertisements
Similar presentations
Volume 134, Issue 7, Pages (June 2008)
Advertisements

Volume 139, Issue 3, Pages e6 (September 2010)
Volume 152, Issue 5, Pages e6 (April 2017)
Pathogenic and Protective Roles of MyD88 in Leukocytes and Epithelial Cells in Mouse Models of Inflammatory Bowel Disease  Mark J. Asquith, Olivier Boulard,
Volume 153, Issue 3, Pages (September 2017)
Covering the Cover Gastroenterology
Volume 2, Issue 4, Pages (October 2005)
Volume 141, Issue 6, Pages e7 (December 2011)
Volume 132, Issue 5, Pages (May 2007)
Volume 140, Issue 2, Pages e2 (February 2011)
Volume 143, Issue 5, Pages e7 (November 2012)
Volume 132, Issue 3, Pages (March 2007)
Volume 137, Issue 4, Pages e3 (October 2009)
Volume 138, Issue 1, Pages (January 2010)
Volume 143, Issue 5, Pages e1 (November 2012)
Volume 126, Issue 3, Pages (March 2004)
Volume 133, Issue 6, Pages (December 2007)
Base Treatment Corrects Defects Due to Misfolding of Mutant Cystic Fibrosis Transmembrane Conductance Regulator  Wan Namkung, Kyung Hwan Kim, Min Goo.
Loss of Claudins 2 and 15 From Mice Causes Defects in Paracellular Na+ Flow and Nutrient Transport in Gut and Leads to Death from Malnutrition  Masami.
Volume 15, Issue 1, Pages (January 2012)
Volume 132, Issue 3, Pages (March 2007)
Gluconeogenic Signals Regulate Iron Homeostasis via Hepcidin in Mice
Covering the Cover Gastroenterology
Volume 138, Issue 5, Pages e1 (May 2010)
Aryl Hydrocarbon Receptor Regulates Pancreatic IL-22 Production and Protects Mice From Acute Pancreatitis  Jing Xue, David T.C. Nguyen, Aida Habtezion 
Volume 143, Issue 5, Pages e4 (November 2012)
Pathogenic and Protective Roles of MyD88 in Leukocytes and Epithelial Cells in Mouse Models of Inflammatory Bowel Disease  Mark J. Asquith, Olivier Boulard,
Reduced Expression of Ferroportin-1 Mediates Hyporesponsiveness of Suckling Rats to Stimuli That Reduce Iron Absorption  Deepak Darshan, Sarah J. Wilkins,
Jack C. Reidling, Nils Lambrecht, Mohammad Kassir, Hamid M. Said 
Volume 136, Issue 2, Pages e1 (February 2009)
Volume 137, Issue 4, Pages e5 (October 2009)
Volume 134, Issue 7, Pages (June 2008)
Volume 140, Issue 5, Pages (May 2011)
Reduced Expression of UGT1A1 in Intestines of Humanized UGT1 Mice via Inactivation of NF-κB Leads to Hyperbilirubinemia  Ryoichi Fujiwara, Shujuan Chen,
Volume 153, Issue 3, Pages (September 2017)
Volume 152, Issue 5, Pages e6 (April 2017)
Volume 137, Issue 3, Pages (September 2009)
Volume 141, Issue 4, Pages e5 (October 2011)
Laminin γ2 Mediates Wnt5a-Induced Invasion of Gastric Cancer Cells
Volume 140, Issue 5, Pages (May 2011)
Volume 139, Issue 4, Pages e8 (October 2010)
Evidence That Gallbladder Epithelial Mucin Enhances Cholesterol Cholelithogenesis in MUC1 Transgenic Mice  Helen H. Wang, Nezam H. Afdhal, Sandra J. Gendler,
Volume 140, Issue 4, Pages e1 (April 2011)
Volume 17, Issue 2, Pages (February 2013)
Abrogation of the Antifibrotic Effects of Natural Killer Cells/Interferon-γ Contributes to Alcohol Acceleration of Liver Fibrosis  Won–Il Jeong, Ogyi.
Volume 140, Issue 7, Pages e2 (June 2011)
Volume 140, Issue 3, Pages e8 (March 2011)
Volume 39, Issue 4, Pages (October 2003)
Volume 13, Issue 8, Pages (November 2015)
Volume 141, Issue 1, Pages e1 (July 2011)
Volume 130, Issue 4, Pages (April 2006)
This Month in Gastroenterology
Volume 136, Issue 4, Pages (April 2009)
Daniel F. Wallace, Lesa Summerville, V. Nathan Subramaniam 
Volume 116, Issue 6, Pages (June 1999)
Volume 135, Issue 2, Pages (August 2008)
Volume 134, Issue 4, Pages (April 2008)
Volume 137, Issue 4, Pages (October 2009)
PPARβ/δ Activation Induces Enteroendocrine L Cell GLP-1 Production
Jinhan He, Shigeru Nishida, Meishu Xu, Makoto Makishima, Wen Xie 
Volume 93, Issue 5, Pages (May 1998)
Volume 136, Issue 3, Pages e2 (March 2009)
The PepT1–NOD2 Signaling Pathway Aggravates Induced Colitis in Mice
Volume 146, Issue 7, Pages e4 (June 2014)
Volume 137, Issue 4, Pages (October 2009)
Heat Shock Transcription Factor 1 Is a Key Determinant of HCC Development by Regulating Hepatic Steatosis and Metabolic Syndrome  Xiongjie Jin, Demetrius.
Antigen-Presenting Cell Production of IL-10 Inhibits T-Helper 1 and 17 Cell Responses and Suppresses Colitis in Mice  Bo Liu, Susan L. Tonkonogy, R. Balfour.
Current Practice in the Diagnosis of Bile Acid Diarrhea
James L. Boyer, Carol J. Soroka  Gastroenterology 
Volume 140, Issue 3, Pages (March 2011)
Presentation transcript:

Volume 142, Issue 7, Pages 1581-1591.e6 (June 2012) Defects in Gallbladder Emptying and Bile Acid Homeostasis in Mice With Cystic Fibrosis Transmembrane Conductance Regulator Deficiencies  Dominique Debray, Dominique Rainteau, Véronique Barbu, Myriam Rouahi, Haquima El Mourabit, Stéphanie Lerondel, Colette Rey, Lydie Humbert, Dominique Wendum, Charles–Henry Cottart, Paul Dawson, Nicolas Chignard, Chantal Housset  Gastroenterology  Volume 142, Issue 7, Pages 1581-1591.e6 (June 2012) DOI: 10.1053/j.gastro.2012.02.033 Copyright © 2012 AGA Institute Terms and Conditions

Figure 1 Gallbladder emptying defect in cftr−/− mice. Overnight-fed cftr−/− mice and cftr+/+ control littermates were subjected to (A) laparotomy and macroscopic examination of the abdominal cavity, showing enlarged gallbladders in cftr−/− mice in comparison with cftr+/+controls (right and left panels, respectively, arrows). (B and C) Scintigraphic analyses of gallbladder motor function. (B) Typical images recorded at the indicated times after intravenous injection of 99mTc-mebrofenin. (C) Representative time-activity curves generated over regions of interest. Gastroenterology 2012 142, 1581-1591.e6DOI: (10.1053/j.gastro.2012.02.033) Copyright © 2012 AGA Institute Terms and Conditions

Figure 2 Mechanisms of gallbladder emptying defect in cftr−/−mice. cftr−/− mice and cftr+/+ control littermates were subjected to the analysis of (A and B) gallbladder motor function assessed by99mTc-mebrofenin scintigraphy, (A) in basal fed conditions and (B) 1 week later, in the same animals, after the subcutaneous injection of CCK-8. In each condition, the time-course of gallbladder radioactivity (expressed as a percentage of total injected activity) is shown in individual animals (left panels), and the corresponding gallbladder ejection fractions (right panels) were calculated at 45 and 120 minutes (means ± standard error of the mean [SEM]). (C) Gallbladder bile volumes after overnight fasting or feeding (means ± SEM of 15 animals). (D) pH (means ± SEM) of the duodenum (n = 15), of hepatic bile (n = 4), and of gallbladder bile (n = 15). (E) Expression of the Vip and Cck genes, analyzed by quantitative reverse-transcription polymerase chain reaction, in the duodenum. The mRNA levels are shown relative to the mean value in cftr+/+ mice (means ± SEM of 6 animals). Gastroenterology 2012 142, 1581-1591.e6DOI: (10.1053/j.gastro.2012.02.033) Copyright © 2012 AGA Institute Terms and Conditions

Figure 3 BA composition and pool size in cftr−/−mice. BA analyses were performed in cftr−/− mice and cftr+/+ control littermates, by HPLC-tandem mass spectrometry, to determine (A) the proportions of primary BAs (cholic acid, muricholic acid, chenodeoxycholic acid, and hyocholic acid), secondary BAs (deoxycholic acid, hyodeoxycholic acid, and lithocholic acid), and ursodeoxycholic acid (UDCA), including their conjugates, in liver tissue (n = 5), gallbladder bile (n = 15), and portal blood (n = 15). Histograms show means (standard error of the mean [SEM] and total concentrations are shown in Table 1). (B) BA pool size and fecal output (means ± SEM of 8 animals). Gastroenterology 2012 142, 1581-1591.e6DOI: (10.1053/j.gastro.2012.02.033) Copyright © 2012 AGA Institute Terms and Conditions

Figure 4 Changes in gene expression underlying BA homeostasis in cftr−/−mice. Gene expression was analyzed by quantitative reverse-transcription polymerase chain reaction (A) in the terminal ileum, (B) in the liver, and (C) in the gallbladder of cftr−/− mice and cftr+/+ control littermates. The mRNA levels are shown relative to the mean value in cftr+/+ mice (means ± standard error of the mean of 6 animals). (D) Protein levels were analyzed by immunoblot in membrane fractions prepared from pooled samples of terminal ileum (n = 2) or gallbladder (n = 10), and were quantified by densitometry. Two bands for ASBT represent different glycosylated forms, as confirmed by peptide:N-glycosidase F digestion (not shown). Gastroenterology 2012 142, 1581-1591.e6DOI: (10.1053/j.gastro.2012.02.033) Copyright © 2012 AGA Institute Terms and Conditions

Figure 5 Visualization of the cholecystohepatic shunt and effect of cholecystectomy on BA homeostasis in cftr−/− mice. (A) Cholyl-(Ne-NBD)-lysine was injected into the gallbladder of cftr−/− mice, after cystic duct ligation. Twenty minutes later, the accumulation of cholyl-(Ne-NBD)-lysine was visible within bile canaliculi, predominantly in the periportal area (lower panel, representative of 5 animals); basal fluorescence in the liver from a noninjected animal is shown in comparison (upper panel). (B–E) Cftr−/− mice with intact gallbladders or that had undergone cholecystectomy 1 month earlier were subjected to reverse-transcription polymerase chain reaction analyses of (B) ileal gene expression, (C) hepatic gene expression, and to HPLC-tandem mass spectrometry analyses. The HPLC-tandem mass spectrometry analyses were performed for (D) BA pool size and (E) individual BAs in portal blood to determine total BA concentrations and the proportion of primary BAs (cholic acid, muricholic acid, chenodeoxycholic acid, and hyocholic acid), secondary BAs (deoxycholic acid, hyodeoxycholic acid, and lithocholic acid), and ursodeoxycholic acid [UDCA], including their conjugates. The mRNA levels are shown relative to the mean value in cftr+/+ mice (means ± standard error of the mean of 6 animals). *P < .05 vs cftr+/+ (as shown in Figure 4A and B). Gastroenterology 2012 142, 1581-1591.e6DOI: (10.1053/j.gastro.2012.02.033) Copyright © 2012 AGA Institute Terms and Conditions

Figure 6 Proposed model of BA recycling in CF. As compared with (A) normal conditions, (B) the duodenum in CF is abnormally acidic and overproduces the relaxing factor VIP, which is also locally produced, together with FGF15, by the gallbladder. Gallbladder emptying is impaired, impeding BA influx into the intestine. BA transporters (closed circles) are down-regulated in the ileum and increased in the gallbladder, providing a cholecystohepatic shunt for BAs. This pathway maintains the level of BA transport back to the liver, and results in a lower proportion of secondary BAs. Gastroenterology 2012 142, 1581-1591.e6DOI: (10.1053/j.gastro.2012.02.033) Copyright © 2012 AGA Institute Terms and Conditions

Supplementary Figure 1 Morphologic features in cftr−/− mice. The following features were recorded in 3-month-old cftr−/− mice and cftr+/+ control littermates older than 3 months: (A) body weight (means ± standard error of the mean of 15 animals), and (B) liver and (C) ileum histology (normal appearance of H&E-stained tissue sections, representative of 30 cftr−/− mice). Gastroenterology 2012 142, 1581-1591.e6DOI: (10.1053/j.gastro.2012.02.033) Copyright © 2012 AGA Institute Terms and Conditions

Supplementary Figure 2 Morphologic features and BA composition in ΔF508 mice. The following parameters were recorded in ΔF508 mice (n = 7) and wild-type (WT) control littermates (n = 7): (A) body weight (means ± standard error of the mean), (B) liver histology (normal appearance of an H&E-stained tissue section, representative of the 7 ΔF508 mice), and (C) BA composition, assessed by HPLC-tandem mass spectrometry analyses. Histograms show the mean proportions of primary BAs (cholic acid, muricholic acid, chenodeoxycholic acid, hyocholic acid), secondary BAs (deoxycholic acid, hyodeoxycholic acid, lithocholic acid), and ursodeoxycholic acid, including their conjugates, in portal blood (total BA concentrations were 118 ± 21.7 μmol/L and 123.39 ± 16.1 μmol/L, in WT and ΔF508 mice, respectively, NS). Gastroenterology 2012 142, 1581-1591.e6DOI: (10.1053/j.gastro.2012.02.033) Copyright © 2012 AGA Institute Terms and Conditions

Supplementary Figure 3 Gallbladder motor function in ΔF508 mice. ΔF508 mice (n = 7) and wild-type (WT) control littermates (n = 7) were subjected to (A–C) scintigraphic analyses of gallbladder motor function in overnight-fed animals. (A) Typical images recorded at the indicated times after intravenous injection of 99mTc-mebrofenin. (B) Representative time-activity curves generated over regions of interest. (C) Gallbladder ejection fractions at 45 and 120 minutes (means ± standard error of the mean [SEM]). (D) Evaluation of gut-derived signaling to the gallbladder, by reverse-transcription polymerase chain reaction (RT-PCR) analyses of Vip and Cck gene expression in the duodenum. The mRNA levels are shown relative to the mean value in WT mice (means ± SEM). Gastroenterology 2012 142, 1581-1591.e6DOI: (10.1053/j.gastro.2012.02.033) Copyright © 2012 AGA Institute Terms and Conditions

Supplementary Figure 4 Time-course analysis of the cholecystohepatic shunt. Cholyl-(Ne-NBD)-lysine was injected in the gallbladder of cftr−/−mice and cftr+/+ control littermates, after ligation of the cystic duct. At 1, 5, or 20 minutes after injection, the liver was collected and fluorescence was analyzed on frozen tissue sections. (A) The absence of cholyl-(Ne-NBD)-lysine leakage from the gallbladder was verified at the end of each experiment. (B) Fluorescence appeared sooner (1 minute) in the knockout, and thereafter increased over time in both cftr−/− mice and cftr+/+ mice; basal fluorescence in the liver from noninjected animals is shown in comparison (0 min). Gastroenterology 2012 142, 1581-1591.e6DOI: (10.1053/j.gastro.2012.02.033) Copyright © 2012 AGA Institute Terms and Conditions

Supplementary Figure 5 Gallbladder expression of Fgf receptor in cftr−/− mice. Fgf receptor 3 and Fgf receptor 4 gene expressions were analyzed by quantitative reverse-transcription polymerase chain reaction in the gallbladder of cftr−/− mice and cftr+/+ control littermates (means ± standard error of the mean of 6 animals). Gastroenterology 2012 142, 1581-1591.e6DOI: (10.1053/j.gastro.2012.02.033) Copyright © 2012 AGA Institute Terms and Conditions